The catabolic action of insulin in the brain is mediated by melanocortins

Journal of Neuroscience

Volumn 22, Issue 20, 2002, Pages 9048-9052

  Benoit, Stephen C ^a   Air, Ellen L ^a   Coolen, Lique M ^b   Strauss, Richelle ^a   Jackman, Alana ^c   Clegg, Deborah J ^a   Seeley, Randy J ^a   Woods, Stephen C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Food intake; Insulin; Leptin; Melanocortins; Obesity; POMC

Indexed keywords

INSULIN; INSULIN RECEPTOR; LEPTIN; MELANOCORTIN; MESSENGER RNA; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY WEIGHT; BRAIN; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; DIET RESTRICTION; FOOD INTAKE; HORMONE ACTION; HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

EID: 0037109670     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-20-09048.2002     Document Type: Article

References (33)

1. Bagdade JD, Bierman EL, Porte Jr D (1967) The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46:1549-1557.
2. Barsh GS, Farooqi IS, O'Rahilly S (2000) Genetics of body-weight regulation. Nature 404:644-651.
3. Baskin DG, Porte DJ, Guest K, Dorsa DM (1983) Regional concentrations of insulin in the rat brain. Endocr J 112:898-903.
4. Baura G, Foster D, Porte Jr D, Kahn SE, Bergman RN, Cobelli C, Schwartz MW (1993) Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: A mechanism for regulated insulin delivery to the brain. J Clin Invest 92:1824-1830.
5. Bjorbaek C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS (1998) Identification of SOCS-3 as a potential mediator of central leptin resistance. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:619-625.
6. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Müller-Wieland D, Kahn CR (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125.
7. Chavez M, Seeley RJ, Woods SC (1995) A comparison between the effects of intraventricular insulin and intraperitoneal LiCl on three measures sensitive to emetic agents. Behav Neurosci 109:547-550.
8. Cheung CC, Clifton DK, Steiner RA (1997) Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489-4492.
9. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411:480-484.
10. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E (2000) SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15985-15991.
11. Fan W, Boston B, Kesterson R, Hruby V, Cone R (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168.
12. Hagan M, Rushing P, Schwartz M, Yagaloff K, Burn P, Woods S, Seeley R (1999) Role of the CNS melanocortin system in the response to overfeeding. J Neurosci 19:2362-2367.
13. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van der Ploeg HT, Woods SC, Seeley RJ (2000) Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol 279:R47-R52.
14. Hunyady B, Krempels K, Harta G, Mezey E (1996) Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem 44:1353-1362.
15. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141.
16. Kim EM, Grace MK, Welch CC, Billington CJ, Levine AS (1999) STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am J Physiol 276: R1320-R1326.
17. McGowan MK, Andrews KM, Grossman SP (1992) Chronic intrahyphothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physol Behav 51:753-766.
18. Medhurst AD, Harrison DC, Read SJ, Campbell CA, Robbins MJ, Pangalos MN (2000) The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models. J Neurosci Methods 98:9-20.
19. Mizuno T, Kleopoulos S, Bergen H, Roberts J, Priest C, Mobbs C (1998) Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47:294-297.
20. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers Jr MG, Schwartz MW (2001) Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 413:794-795.
21. Ollmann M, Wilson B, Yang Y, Kerns J, Chen Y, Gantz I, Barsh G (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135-138.
22. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D (1992) Insulin in the brain: A hormonal regulator of energy balance. Endocr Rev 13:387-414.
23. Schwartz MW, Seeley RJ, Weigle DS, Burn P, Campfield LA, Baskin DG (1997) Leptin increases hypothalamic proopiomelanocoritin (POMC) mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123.
24. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671.
25. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk D, Baskin DG, Schwartz MW (1997) Melanocortin receptors in leptin effects. Nature 390:349.
26. Stubdal H, Lynch CA, Moriarty A, Fang Q, Chickering T, Deeds JD, Fairchild-Huntress V, Charlat O, Dunmore JH, Kleyn P, Huszar DK, R (2000) Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation. Mol Cell Biol 20:878-882.
27. Thiele T, van DG, Yagaloff K, Fisher S, Schwartz M, Burn P, Seeley R (1998) Central infusion of melanocortin agonist MTII in rats: Assessment of c-Fos expression and taste aversion. Am J Physiol 274:R248-R254.
28. Thornton JE, Cheung CC, Clifton DK, Steiner RA (1997) Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138:5063-5067.
29. Watson Jr RE, Wiegand SJ, Clough RW, Hoffman GE (1986) Use of a cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7:155-159.
30. Woods SC, Decke E, Vasselli JR (1974) Metabolic hormones and regulation of body weight. Psychol Rev 81:26-43.
31. Woods SC, Lotter EC, McKay LD, Porte Jr D (1979) Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282:503-505.
32. Woods SC, Seeley RJ, Porte DJ, Schwartz MW (1998) Signals that regulate food intake and energy homeostasis. Science 280:1378-1383.
33. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070.